欧盟EMA药品数据库-欧盟集中审批药品
(European Medicines Agency Authorisation of Medicines DataBase)
商品名称 适用类别 通用名称 活性成分 产品号 上市许可开发者/申请人/持有人 上市许可日期 许可状态
Xevudy Human sotrovimab sotrovimab EMEA/H/C/005676 GlaxoSmithKline Trading Services Limited 2026/02/18 Withdrawn
Anktiva Human nogapendekin alfa inbakicept nogapendekin alfa inbakicept EMEA/H/C/006622 Immunitybio Ireland Limited 2026/02/16 Authorised
Exdensur Human depemokimab depemokimab EMEA/H/C/006446 GlaxoSmithKline Trading Services Limited 2026/02/12 Authorised
mNexspike Human COVID-19 mRNA vaccine single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA template, encoding the N-terminal domain and receptor-binding domain of the viral spike (S) protein of SARS-CoV-2 EMEA/H/C/006428 Moderna Biotech Spain, S.L. 2026/02/12 Authorised
Myqorzo Human aficamten aficamten EMEA/H/C/006228 Cytokinetics (Ireland) Limited 2026/02/12 Authorised
Aumseqa Human Aumolertinib Aumolertinib mesilate EMEA/H/C/006069 SFL Pharmaceuticals Deutschland GmbH 2026/02/12 Authorised
Gotenfia Human golimumab golimumab EMEA/H/C/006621 Stada Arzneimittel AG 2026/02/10 Authorised
Ranluspec Human ranibizumab ranibizumab EMEA/H/C/006502 Lupin Europe GmbH 2026/02/10 Authorised
Aqneursa Human L-acetylleucine L-acetylleucine EMEA/H/C/006327 Intrabio Ireland Limited 2026/01/19 Authorised
Dawnzera Human donidalorsen donidalorsen EMEA/H/C/006554 Otsuka Pharmaceutical Netherlands B.V. 2026/01/19 Authorised
Waskyra Human etuvetidigene autotemcel genetically modified autologous CD34+ cell enriched population that contains haematopoietic stem and progenitor cells (HSPC) transduced ex vivo using a lentiviral vector encoding the human Wiskott-Aldrich Syndrome (WAS) gene EMEA/H/C/006525 Fondazione Telethon ETS 2026/01/09 Authorised
VacPertagen Human pertussis vaccine (recombinant, acellular, component, adsorbed) recombinant pertussis toxin;filamentous haemagglutinin EMEA/H/C/006304 BioNet Europe 2026/01/09 Authorised
Inluriyo Human imlunestrant imlunestrant tosilate EMEA/H/C/006184 Eli Lilly Nederland B.V. 2026/01/09 Authorised
Teduglutide Viatris Human teduglutide teduglutide EMEA/H/C/006564 Viatris Limited 2026/01/08 Authorised
Osqay Human denosumab denosumab EMEA/H/C/006492 Theramex Ireland Limited 2026/01/08 Authorised
Teizeild Human teplizumab teplizumab EMEA/H/C/005496 Sanofi Winthrop Industrie 2026/01/08 Authorised
Austedo Human deutetrabenazine deutetrabenazine EMEA/H/C/006371 Teva GmbH 2026/01/08 Authorised
GalenVita Human germanium (68Ge) chloride;gallium (68Ga) chloride germanium (68Ge) chloride;gallium (68Ga) chloride EMEA/H/C/006639 Curium Romania S.R.L. 2026/01/08 Authorised
Wayrilz Human rilzabrutinib rilzabrutinib EMEA/H/C/006425 Sanofi B.V. 2025/12/22 Authorised
Imaavy Human nipocalimab nipocalimab EMEA/H/C/006379 Janssen Cilag International NV 2025/11/28 Authorised

数据库说明:

©2006-2026 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase